ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Implantable Glaucoma Device Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-38V14115
Home | Market Reports | Health| Vision Care
Global Implantable Glaucoma Device Market Research Report 2023
BUY CHAPTERS

Global Implantable Glaucoma Device Market Research Report 2025

Code: QYRE-Auto-38V14115
Report
February 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Glaukos Corp
Ocular Therapeutix
PolyActiva
Nova Eye Medical
Alcon
iSTAR Medical
Henan Universe
Health Guard Biomed

The global market for Implantable Glaucoma Device was valued at US$ 1325 million in the year 2024 and is projected to reach a revised size of US$ 3145 million by 2031, growing at a CAGR of 13.3% during the forecast period.

Implantable Glaucoma Device Market

Implantable Glaucoma Device Market

A glaucoma drainage implant is a small device placed in the eye to treat glaucoma. There are many different ways to treat glaucoma. In addition to conventional and laser surgery, there are a variety of drugs to lower intraocular pressure (IOP). If these methods alone fail, doctors may suggest implants.
It is understood that glaucoma is an irreversible blinding eye disease that is highly harmful and irreversible. It is estimated that there are about 21.8 million glaucoma patients in my country. Glaucoma brings heavy economic burdens and physiological and psychological distress to patients and society.
Glaucoma blindness is a chronic process. Early detection and reasonable and effective treatment can avoid blindness. Lowering intraocular pressure to treat open-angle glaucoma (POAG) is currently the only proven effective method to delay the progression of glaucoma. For every 1 mmHg drop in intraocular pressure, the risk of glaucoma progression is reduced by 10%. The European, American and Asia-Pacific Glaucoma Associations and my country's glaucoma diagnosis and treatment guidelines all recommend the setting of target intraocular pressure. The main methods of treating glaucoma in my country include drugs, lasers and surgery. However, due to the complexity of risk factors, target intraocular pressure is not the same, and individual responsiveness to treatment varies. It has been reported that 1/3 of patients do not meet the target intraocular pressure, which means that they will find it difficult to maintain good vision and quality of life during their lifetime. Therefore, it is urgent to develop new methods to solve this problem. Internationally, new, minimally invasive, and biocompatible drainage devices provide more options and better solutions for glaucoma treatment.
On January 9, 2021, China's first Santian PRESERFLO drainage device implantation surgery was completed at the Boao Super Hospital in the Boao Lecheng Pilot Zone. The surgery was performed by Professor Zhang Shaodan of the International Eye and Optometry Center of the Boao Super Hospital and the Affiliated Eye and Optometry Hospital of Wenzhou Medical University. The successful completion of the surgery means that my country has achieved another major breakthrough in the field of glaucoma treatment, bringing new hope to the vast number of glaucoma patients in my country. PRESERFLO™ MICROSHUNT is an innovative glaucoma drainage device, which is a minimally invasive surgery for the treatment of glaucoma. Compared with traditional glaucoma filtration surgery, minimally invasive glaucoma surgery is considered to be less damaging, safer, and has a faster recovery after surgery while ensuring efficacy.
Market development trend
Technological innovation: With the continuous advancement of science and technology, implantable glaucoma devices will continue to introduce new technologies and new materials to improve product performance and safety. For example, the integration of intelligent technology will make glaucoma shunts more accurate and efficient.
Personalized treatment: With the improvement of medical standards and the diversification of patient needs, personalized treatment will become an important development direction of the implantable glaucoma device market. Enterprises need to provide customized products and services according to the specific conditions of patients to meet their personalized needs.
Internationalization strategy: With the development of global economic integration, the demand for implantable glaucoma devices in the international market is also increasing. Enterprises will strengthen international cooperation and expand overseas markets to achieve market expansion and global business layout.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Implantable Glaucoma Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Glaucoma Device.
The Implantable Glaucoma Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Glaucoma Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Glaucoma Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Implantable Glaucoma Device Market Report

Report Metric Details
Report Name Implantable Glaucoma Device Market
Accounted market size in year US$ 1325 million
Forecasted market size in 2031 US$ 3145 million
CAGR 13.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Trabecular Meshwork-Schlemm Canal Drainage
  • Subconjunctival Drainage
  • Others
Segment by Application
  • Hospital
  • Ophthalmology Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, Ocular Therapeutix, PolyActiva, Health Guard Biomed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Implantable Glaucoma Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Implantable Glaucoma Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Implantable Glaucoma Device Market growing?

Ans: The Implantable Glaucoma Device Market witnessing a CAGR of 13.3% during the forecast period 2025-2031.

What is the Implantable Glaucoma Device Market size in 2031?

Ans: The Implantable Glaucoma Device Market size in 2031 will be US$ 3145 million.

Who are the main players in the Implantable Glaucoma Device Market report?

Ans: The main players in the Implantable Glaucoma Device Market are AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, Ocular Therapeutix, PolyActiva, Health Guard Biomed

What are the Application segmentation covered in the Implantable Glaucoma Device Market report?

Ans: The Applications covered in the Implantable Glaucoma Device Market report are Hospital, Ophthalmology Clinics, Others

What are the Type segmentation covered in the Implantable Glaucoma Device Market report?

Ans: The Types covered in the Implantable Glaucoma Device Market report are Trabecular Meshwork-Schlemm Canal Drainage, Subconjunctival Drainage, Others

Recommended Reports

Glaucoma Devices

Ophthalmic Surgery

Ophthalmic Treatments

1 Implantable Glaucoma Device Market Overview
1.1 Product Definition
1.2 Implantable Glaucoma Device by Type
1.2.1 Global Implantable Glaucoma Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trabecular Meshwork-Schlemm Canal Drainage
1.2.3 Subconjunctival Drainage
1.2.4 Others
1.3 Implantable Glaucoma Device by Application
1.3.1 Global Implantable Glaucoma Device Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Ophthalmology Clinics
1.3.4 Others
1.4 Global Implantable Glaucoma Device Market Size Estimates and Forecasts
1.4.1 Global Implantable Glaucoma Device Revenue 2020-2031
1.4.2 Global Implantable Glaucoma Device Sales 2020-2031
1.4.3 Global Implantable Glaucoma Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Implantable Glaucoma Device Market Competition by Manufacturers
2.1 Global Implantable Glaucoma Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Implantable Glaucoma Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Implantable Glaucoma Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Implantable Glaucoma Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Implantable Glaucoma Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Implantable Glaucoma Device, Product Type & Application
2.7 Global Key Manufacturers of Implantable Glaucoma Device, Date of Enter into This Industry
2.8 Global Implantable Glaucoma Device Market Competitive Situation and Trends
2.8.1 Global Implantable Glaucoma Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Implantable Glaucoma Device Players Market Share by Revenue
2.8.3 Global Implantable Glaucoma Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Implantable Glaucoma Device Market Scenario by Region
3.1 Global Implantable Glaucoma Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Implantable Glaucoma Device Sales by Region: 2020-2031
3.2.1 Global Implantable Glaucoma Device Sales by Region: 2020-2025
3.2.2 Global Implantable Glaucoma Device Sales by Region: 2026-2031
3.3 Global Implantable Glaucoma Device Revenue by Region: 2020-2031
3.3.1 Global Implantable Glaucoma Device Revenue by Region: 2020-2025
3.3.2 Global Implantable Glaucoma Device Revenue by Region: 2026-2031
3.4 North America Implantable Glaucoma Device Market Facts & Figures by Country
3.4.1 North America Implantable Glaucoma Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Implantable Glaucoma Device Sales by Country (2020-2031)
3.4.3 North America Implantable Glaucoma Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Implantable Glaucoma Device Market Facts & Figures by Country
3.5.1 Europe Implantable Glaucoma Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Implantable Glaucoma Device Sales by Country (2020-2031)
3.5.3 Europe Implantable Glaucoma Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Glaucoma Device Market Facts & Figures by Region
3.6.1 Asia Pacific Implantable Glaucoma Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Implantable Glaucoma Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Implantable Glaucoma Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Implantable Glaucoma Device Market Facts & Figures by Country
3.7.1 Latin America Implantable Glaucoma Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Implantable Glaucoma Device Sales by Country (2020-2031)
3.7.3 Latin America Implantable Glaucoma Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Implantable Glaucoma Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Glaucoma Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Implantable Glaucoma Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Implantable Glaucoma Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Glaucoma Device Sales by Type (2020-2031)
4.1.1 Global Implantable Glaucoma Device Sales by Type (2020-2025)
4.1.2 Global Implantable Glaucoma Device Sales by Type (2026-2031)
4.1.3 Global Implantable Glaucoma Device Sales Market Share by Type (2020-2031)
4.2 Global Implantable Glaucoma Device Revenue by Type (2020-2031)
4.2.1 Global Implantable Glaucoma Device Revenue by Type (2020-2025)
4.2.2 Global Implantable Glaucoma Device Revenue by Type (2026-2031)
4.2.3 Global Implantable Glaucoma Device Revenue Market Share by Type (2020-2031)
4.3 Global Implantable Glaucoma Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Implantable Glaucoma Device Sales by Application (2020-2031)
5.1.1 Global Implantable Glaucoma Device Sales by Application (2020-2025)
5.1.2 Global Implantable Glaucoma Device Sales by Application (2026-2031)
5.1.3 Global Implantable Glaucoma Device Sales Market Share by Application (2020-2031)
5.2 Global Implantable Glaucoma Device Revenue by Application (2020-2031)
5.2.1 Global Implantable Glaucoma Device Revenue by Application (2020-2025)
5.2.2 Global Implantable Glaucoma Device Revenue by Application (2026-2031)
5.2.3 Global Implantable Glaucoma Device Revenue Market Share by Application (2020-2031)
5.3 Global Implantable Glaucoma Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Implantable Glaucoma Device Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Santen Pharmaceutical
6.2.1 Santen Pharmaceutical Company Information
6.2.2 Santen Pharmaceutical Description and Business Overview
6.2.3 Santen Pharmaceutical Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Santen Pharmaceutical Implantable Glaucoma Device Product Portfolio
6.2.5 Santen Pharmaceutical Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Company Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson and Johnson Implantable Glaucoma Device Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Advanced Ophthalmic Innovations (AOI)
6.4.1 Advanced Ophthalmic Innovations (AOI) Company Information
6.4.2 Advanced Ophthalmic Innovations (AOI) Description and Business Overview
6.4.3 Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Product Portfolio
6.4.5 Advanced Ophthalmic Innovations (AOI) Recent Developments/Updates
6.5 New World Medical
6.5.1 New World Medical Company Information
6.5.2 New World Medical Description and Business Overview
6.5.3 New World Medical Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 New World Medical Implantable Glaucoma Device Product Portfolio
6.5.5 New World Medical Recent Developments/Updates
6.6 Nova Eye Medical
6.6.1 Nova Eye Medical Company Information
6.6.2 Nova Eye Medical Description and Business Overview
6.6.3 Nova Eye Medical Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nova Eye Medical Implantable Glaucoma Device Product Portfolio
6.6.5 Nova Eye Medical Recent Developments/Updates
6.7 Glaukos Corp
6.7.1 Glaukos Corp Company Information
6.7.2 Glaukos Corp Description and Business Overview
6.7.3 Glaukos Corp Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Glaukos Corp Implantable Glaucoma Device Product Portfolio
6.7.5 Glaukos Corp Recent Developments/Updates
6.8 Alcon
6.8.1 Alcon Company Information
6.8.2 Alcon Description and Business Overview
6.8.3 Alcon Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Alcon Implantable Glaucoma Device Product Portfolio
6.8.5 Alcon Recent Developments/Updates
6.9 iSTAR Medical
6.9.1 iSTAR Medical Company Information
6.9.2 iSTAR Medical Description and Business Overview
6.9.3 iSTAR Medical Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 iSTAR Medical Implantable Glaucoma Device Product Portfolio
6.9.5 iSTAR Medical Recent Developments/Updates
6.10 Henan Universe
6.10.1 Henan Universe Company Information
6.10.2 Henan Universe Description and Business Overview
6.10.3 Henan Universe Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Henan Universe Implantable Glaucoma Device Product Portfolio
6.10.5 Henan Universe Recent Developments/Updates
6.11 Ocular Therapeutix
6.11.1 Ocular Therapeutix Company Information
6.11.2 Ocular Therapeutix Description and Business Overview
6.11.3 Ocular Therapeutix Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ocular Therapeutix Implantable Glaucoma Device Product Portfolio
6.11.5 Ocular Therapeutix Recent Developments/Updates
6.12 PolyActiva
6.12.1 PolyActiva Company Information
6.12.2 PolyActiva Description and Business Overview
6.12.3 PolyActiva Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 PolyActiva Implantable Glaucoma Device Product Portfolio
6.12.5 PolyActiva Recent Developments/Updates
6.13 Health Guard Biomed
6.13.1 Health Guard Biomed Company Information
6.13.2 Health Guard Biomed Description and Business Overview
6.13.3 Health Guard Biomed Implantable Glaucoma Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Health Guard Biomed Implantable Glaucoma Device Product Portfolio
6.13.5 Health Guard Biomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Glaucoma Device Industry Chain Analysis
7.2 Implantable Glaucoma Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Glaucoma Device Production Mode & Process Analysis
7.4 Implantable Glaucoma Device Sales and Marketing
7.4.1 Implantable Glaucoma Device Sales Channels
7.4.2 Implantable Glaucoma Device Distributors
7.5 Implantable Glaucoma Device Customer Analysis
8 Implantable Glaucoma Device Market Dynamics
8.1 Implantable Glaucoma Device Industry Trends
8.2 Implantable Glaucoma Device Market Drivers
8.3 Implantable Glaucoma Device Market Challenges
8.4 Implantable Glaucoma Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Glaukos Corp
Ocular Therapeutix
PolyActiva
Nova Eye Medical
Alcon
iSTAR Medical
Henan Universe
Health Guard Biomed
List of Tables
 Table 1. Global Implantable Glaucoma Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Implantable Glaucoma Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Implantable Glaucoma Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Implantable Glaucoma Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Implantable Glaucoma Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Implantable Glaucoma Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Implantable Glaucoma Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Implantable Glaucoma Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Implantable Glaucoma Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Implantable Glaucoma Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Implantable Glaucoma Device, Product Type & Application
 Table 12. Global Key Manufacturers of Implantable Glaucoma Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Implantable Glaucoma Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Glaucoma Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Implantable Glaucoma Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Implantable Glaucoma Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Implantable Glaucoma Device Sales Market Share by Region (2020-2025)
 Table 19. Global Implantable Glaucoma Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Implantable Glaucoma Device Sales Market Share by Region (2026-2031)
 Table 21. Global Implantable Glaucoma Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Implantable Glaucoma Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Implantable Glaucoma Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Implantable Glaucoma Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Implantable Glaucoma Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Implantable Glaucoma Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Implantable Glaucoma Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Implantable Glaucoma Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Implantable Glaucoma Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Implantable Glaucoma Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Implantable Glaucoma Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Implantable Glaucoma Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Implantable Glaucoma Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Implantable Glaucoma Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Implantable Glaucoma Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Implantable Glaucoma Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Implantable Glaucoma Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Implantable Glaucoma Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Implantable Glaucoma Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Implantable Glaucoma Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Implantable Glaucoma Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Implantable Glaucoma Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Implantable Glaucoma Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Implantable Glaucoma Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Implantable Glaucoma Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Implantable Glaucoma Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Implantable Glaucoma Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Implantable Glaucoma Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Implantable Glaucoma Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Implantable Glaucoma Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Implantable Glaucoma Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Implantable Glaucoma Device Sales Market Share by Type (2020-2025)
 Table 53. Global Implantable Glaucoma Device Sales Market Share by Type (2026-2031)
 Table 54. Global Implantable Glaucoma Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Implantable Glaucoma Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Implantable Glaucoma Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Implantable Glaucoma Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Implantable Glaucoma Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Implantable Glaucoma Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Implantable Glaucoma Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Implantable Glaucoma Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Implantable Glaucoma Device Sales Market Share by Application (2020-2025)
 Table 63. Global Implantable Glaucoma Device Sales Market Share by Application (2026-2031)
 Table 64. Global Implantable Glaucoma Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Implantable Glaucoma Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Implantable Glaucoma Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Implantable Glaucoma Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Implantable Glaucoma Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Implantable Glaucoma Device Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Implantable Glaucoma Device Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Santen Pharmaceutical Company Information
 Table 76. Santen Pharmaceutical Description and Business Overview
 Table 77. Santen Pharmaceutical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Santen Pharmaceutical Implantable Glaucoma Device Product
 Table 79. Santen Pharmaceutical Recent Developments/Updates
 Table 80. Johnson and Johnson Company Information
 Table 81. Johnson and Johnson Description and Business Overview
 Table 82. Johnson and Johnson Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson and Johnson Implantable Glaucoma Device Product
 Table 84. Johnson and Johnson Recent Developments/Updates
 Table 85. Advanced Ophthalmic Innovations (AOI) Company Information
 Table 86. Advanced Ophthalmic Innovations (AOI) Description and Business Overview
 Table 87. Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Product
 Table 89. Advanced Ophthalmic Innovations (AOI) Recent Developments/Updates
 Table 90. New World Medical Company Information
 Table 91. New World Medical Description and Business Overview
 Table 92. New World Medical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. New World Medical Implantable Glaucoma Device Product
 Table 94. New World Medical Recent Developments/Updates
 Table 95. Nova Eye Medical Company Information
 Table 96. Nova Eye Medical Description and Business Overview
 Table 97. Nova Eye Medical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Nova Eye Medical Implantable Glaucoma Device Product
 Table 99. Nova Eye Medical Recent Developments/Updates
 Table 100. Glaukos Corp Company Information
 Table 101. Glaukos Corp Description and Business Overview
 Table 102. Glaukos Corp Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Glaukos Corp Implantable Glaucoma Device Product
 Table 104. Glaukos Corp Recent Developments/Updates
 Table 105. Alcon Company Information
 Table 106. Alcon Description and Business Overview
 Table 107. Alcon Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Alcon Implantable Glaucoma Device Product
 Table 109. Alcon Recent Developments/Updates
 Table 110. iSTAR Medical Company Information
 Table 111. iSTAR Medical Description and Business Overview
 Table 112. iSTAR Medical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. iSTAR Medical Implantable Glaucoma Device Product
 Table 114. iSTAR Medical Recent Developments/Updates
 Table 115. Henan Universe Company Information
 Table 116. Henan Universe Description and Business Overview
 Table 117. Henan Universe Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Henan Universe Implantable Glaucoma Device Product
 Table 119. Henan Universe Recent Developments/Updates
 Table 120. Ocular Therapeutix Company Information
 Table 121. Ocular Therapeutix Description and Business Overview
 Table 122. Ocular Therapeutix Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Ocular Therapeutix Implantable Glaucoma Device Product
 Table 124. Ocular Therapeutix Recent Developments/Updates
 Table 125. PolyActiva Company Information
 Table 126. PolyActiva Description and Business Overview
 Table 127. PolyActiva Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. PolyActiva Implantable Glaucoma Device Product
 Table 129. PolyActiva Recent Developments/Updates
 Table 130. Health Guard Biomed Company Information
 Table 131. Health Guard Biomed Description and Business Overview
 Table 132. Health Guard Biomed Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Health Guard Biomed Implantable Glaucoma Device Product
 Table 134. Health Guard Biomed Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Implantable Glaucoma Device Distributors List
 Table 138. Implantable Glaucoma Device Customers List
 Table 139. Implantable Glaucoma Device Market Trends
 Table 140. Implantable Glaucoma Device Market Drivers
 Table 141. Implantable Glaucoma Device Market Challenges
 Table 142. Implantable Glaucoma Device Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Implantable Glaucoma Device
 Figure 2. Global Implantable Glaucoma Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Implantable Glaucoma Device Market Share by Type: 2024 & 2031
 Figure 4. Trabecular Meshwork-Schlemm Canal Drainage Product Picture
 Figure 5. Subconjunctival Drainage Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Implantable Glaucoma Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Implantable Glaucoma Device Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Ophthalmology Clinics
 Figure 11. Others
 Figure 12. Global Implantable Glaucoma Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Implantable Glaucoma Device Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Implantable Glaucoma Device Sales (2020-2031) & (K Units)
 Figure 15. Global Implantable Glaucoma Device Average Price (US$/Unit) & (2020-2031)
 Figure 16. Implantable Glaucoma Device Report Years Considered
 Figure 17. Implantable Glaucoma Device Sales Share by Manufacturers in 2024
 Figure 18. Global Implantable Glaucoma Device Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Implantable Glaucoma Device Players: Market Share by Revenue in Implantable Glaucoma Device in 2024
 Figure 20. Implantable Glaucoma Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Implantable Glaucoma Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Implantable Glaucoma Device Sales Market Share by Country (2020-2031)
 Figure 23. North America Implantable Glaucoma Device Revenue Market Share by Country (2020-2031)
 Figure 24. United States Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Implantable Glaucoma Device Sales Market Share by Country (2020-2031)
 Figure 27. Europe Implantable Glaucoma Device Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Implantable Glaucoma Device Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Implantable Glaucoma Device Revenue Market Share by Region (2020-2031)
 Figure 35. China Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Implantable Glaucoma Device Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Implantable Glaucoma Device Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Implantable Glaucoma Device Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Implantable Glaucoma Device Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Implantable Glaucoma Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Implantable Glaucoma Device by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Implantable Glaucoma Device by Type (2020-2031)
 Figure 54. Global Implantable Glaucoma Device Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Implantable Glaucoma Device by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Implantable Glaucoma Device by Application (2020-2031)
 Figure 57. Global Implantable Glaucoma Device Price (US$/Unit) by Application (2020-2031)
 Figure 58. Implantable Glaucoma Device Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Glaucoma Implant Device Market Research Report 2025
Global Glaucoma Aqueous Shunt Market Research Report 2024
Global Glaucoma Drainage Devices Market Research Report 2024
Global Minimally Invasive Glaucoma Drainage Tube Market Research Report 2025
Global Glaucoma Drainage Tubes Market Research Report 2024
Global Glaucoma Drainage Implant Market Research Report 2024
Global Glaucoma Treatment Devices Market Research Report 2024
Global Aqueous Shunts and Stents for Glaucoma Market Research Report 2024
Global Glaucoma Drainage Valve Market Research Report 2025
Global Glaucoma Laser Devices Market Research Report 2024
Global Ventricular Drainage Devices Market Research Report 2024
Global Selective Laser Trabeculoplasty SLT Device Market Research Report 2024
Global Glaucoma Surgery Therapies Market Research Report 2024
Global Nasolacrimal Stents Market Research Report 2024
Global Bioresorbable Ocular Implant Market Research Report 2025
Global Lacrimal Duct Stent System Market Research Report 2025
Global Glaucoma Implant Market Research Report 2024
Global Micro Invasive Glaucoma Implants Market Research Report 2024
Global Tear Duct Occluder Market Research Report 2024
Global Internal Urinary Incontinence Device Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions